SCHEMBL9738348

SCHEMBL9738348

COC(=O)c1ccc(OCC(O)CCc2ccc(C(C)(C)C(=O)OC)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.49
TSHR P16473 1/20 0.49
ALDH1A1 P00352 2/20 0.48
LMNA P02545 2/20 0.48
ADRB2 P07550 4/20 0.46
ADRB3 P13945 4/20 0.46
ADRB1 P08588 3/20 0.46
BRS3 P32247 1/20 0.45
MAPT P10636 3/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10820832 0.90 CA1 (0.52) GAATSHRALDH1A1LMNAADRB2
SCHEMBL9485011 0.90 CA1 (0.52) GAATSHRALDH1A1LMNAADRB2
SCHEMBL9736669 0.81 RXRA (0.51) LMNAADRB2ADRB3ADRB1MAPT
SCHEMBL28335565 0.78 LMNA (0.69) GAATSHRALDH1A1LMNAMAPT
Lifibrol SCHEMBL140583 0.78 NR4A2 (0.64) GAAALDH1A1LMNAMAPTMEN1
Lifibrol SCHEMBL9484778 0.78 NR4A2 (0.64) GAAALDH1A1LMNAMAPTMEN1
Lifibrol SCHEMBL9478310 0.78 NR4A2 (0.64) GAAALDH1A1LMNAMAPTMEN1
SCHEMBL9660242 0.77 AR (0.46) GAAALDH1A1LMNAADRB2ADRB3
SCHEMBL6656906 0.76 CYP4A11 (0.62) ALDH1A1MAPTCA12CA1CA2
SCHEMBL9129171 0.76 CA1 (0.53) TSHRALDH1A1MAPTCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153353-A Antilipemic agents KLINGE PHARMA GMBH (DE) 1992-10-06 US disclosed